BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18768187)

  • 21. Characterization of the humoral immune response in alpacas (Lama pacos) experimentally infected with Fasciola hepatica against cysteine proteinases Fas1 and Fas2 and histopathological findings.
    Timoteo O; Maco V; Maco V; Neyra V; Yi PJ; Leguía G; Espinoza JR
    Vet Immunol Immunopathol; 2005 Jun; 106(1-2):77-86. PubMed ID: 15910994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 2.9 kDa Fasciola hepatica-recombinant protein based ELISA test for the detection of current-ovine fasciolosis trickle infected.
    Arias M; Hillyer GV; Sánchez-Andrade R; Suárez JL; Pedreira J; Lomba C; Díaz P; Morrondo P; Díez-Baños P; Paz-Silva A
    Vet Parasitol; 2006 Apr; 137(1-2):67-73. PubMed ID: 16417971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fasciola hepatica: partial characterization of circulating antigens.
    Rodriguez-Osorio M; Rojas J; Gómez-García V
    J Parasitol; 1998 Oct; 84(5):1053-5. PubMed ID: 9794656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoprophylaxis against Fasciola hepatica in rabbits using a recombinant Fh15 fatty acid-binding protein.
    Casanueva R; Hillyer GV; Ramajo V; Oleaga A; Espinoza EY; Muro A
    J Parasitol; 2001 Jun; 87(3):697-700. PubMed ID: 11426738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination with cathepsin L mimotopes of Fasciola hepatica in goats reduces worm burden, morphometric measurements, and reproductive structures.
    Villa-Mancera A; Alcalá-Canto Y; Olivares-Pérez J; Molina-Mendoza P; Hernández-Guzmán K; Utrera-Quintana F; Carreón-Luna L; Olmedo-Juárez A; Reynoso-Palomar A
    Microb Pathog; 2021 Jun; 155():104859. PubMed ID: 33845124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of clorsulon for the treatment of experimentally induced infections of Fasciola hepatica in goats.
    Sundlof SF; Bliss EL; Greiner EC; Tran TQ; Wertenberger MA
    Am J Vet Res; 1991 Jan; 52(1):111-4. PubMed ID: 2021237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fasciola hepatica: an antigen fraction derived from newly excysted juveniles, containing an immunoreactive 32-kDa protein, induces strong protective immunity in rats.
    van Milligen FJ; Cornelissen JB; Bokhout BA
    Exp Parasitol; 2000 Mar; 94(3):163-71. PubMed ID: 10831381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adoptive transfer of dendritic cells pulsed with Fasciola hepatica antigens and lipopolysaccharides confers protection against fasciolosis in mice.
    Falcón CR; Carranza FA; Aoki P; Motrán CC; Cervi L
    J Infect Dis; 2012 Feb; 205(3):506-14. PubMed ID: 21949043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological and immunohistochemical study of the liver and hepatic lymph nodes in goats infected with one or more doses of Fasciola hepatica.
    Pérez J; Martín de las Mulas J; Carrasco L; Gutierrez PN; Martínez-Cruz MS; Martínez-Moreno A
    J Comp Pathol; 1999 Feb; 120(2):199-210. PubMed ID: 10087493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD.
    Martínez-Fernández AR; Nogal-Ruiz JJ; López-Abán J; Ramajo V; Oleaga A; Manga-González Y; Hillyer GV; Muro A
    Vet Parasitol; 2004 Dec; 126(3):287-98. PubMed ID: 15567592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke.
    Wedrychowicz H; Kesik M; Kaliniak M; Kozak-Cieszczyk M; Jedlina-Panasiuk L; Jaros S; Plucienniczak A
    Vet Parasitol; 2007 Jun; 147(1-2):77-88. PubMed ID: 17481823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of immunologic response in rats immunized orally or intramuscularly with cDNA and recombinant protein of the S-glutathione transferase from Fasciola Hepatica].
    Panasiuk LJ
    Wiad Parazytol; 2004; 50(4):757-8. PubMed ID: 16862814
    [No Abstract]   [Full Text] [Related]  

  • 33. Susceptibility to homologous reinfection with Fasciola gigantica in goats.
    Goraish IA; Abdelsalam EB; Tartour G
    Rev Elev Med Vet Pays Trop; 1991; 44(1):69-73. PubMed ID: 1775694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fasciola hepatica and Fasciola gigantica: comparison of cellular response to experimental infection in sheep.
    Zhang WY; Moreau E; Hope JC; Howard CJ; Huang WY; Chauvin A
    Exp Parasitol; 2005 Nov; 111(3):154-9. PubMed ID: 16126202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of immune responses and protective efficacy in a goat model following immunization with a coctail of recombinant antigens and a polyprotein of Mycobacterium avium subsp. paratuberculosis.
    Kathaperumal K; Kumanan V; McDonough S; Chen LH; Park SU; Moreira MA; Akey B; Huntley J; Chang CF; Chang YF
    Vaccine; 2009 Jan; 27(1):123-35. PubMed ID: 18955101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Sigma class glutathione transferase from the liver fluke Fasciola hepatica.
    LaCourse EJ; Perally S; Morphew RM; Moxon JV; Prescott M; Dowling DJ; O'Neill SM; Kipar A; Hetzel U; Hoey E; Zafra R; Buffoni L; Pérez Arévalo J; Brophy PM
    PLoS Negl Trop Dis; 2012; 6(5):e1666. PubMed ID: 22666515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative responses during bacterial phagocytosis of polymorphonuclear leucocytes in primarily and secondarily Fasciola hepatica infected goats.
    Martínez-Moreno A; Jiménez-Luque V; Cámara S; Martínez-Moreno FJ; Acosta I; Hernández S
    Int J Parasitol; 2000 Aug; 30(9):1013-7. PubMed ID: 10980292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccines against the zoonotic trematodes Schistosoma japonicum, Fasciola hepatica and Fasciola gigantica.
    McManus DP; Dalton JP
    Parasitology; 2006; 133 Suppl():S43-61. PubMed ID: 17274848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination against schistosomiasis and fascioliasis with the new recombinant antigen Sm14: potential basis of a multi-valent anti-helminth vaccine?
    Tendler M; Vilar MM; Brito CA; Freire NM; Katz N; Simpson A
    Mem Inst Oswaldo Cruz; 1995; 90(2):255-6. PubMed ID: 8531667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica.
    Valero MA; Ubeira FM; Khoubbane M; Artigas P; Muiño L; Mezo M; Pérez-Crespo I; Periago MV; Mas-Coma S
    Vet Parasitol; 2009 Jan; 159(1):77-81. PubMed ID: 19019548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.